Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of α-adrenoreceptor Antagonists market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of α-adrenoreceptor Antagonistsmarket, defines the market attractiveness level of α-adrenoreceptor Antagonists market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of α-adrenoreceptor Antagonists industry, describes the types of α-adrenoreceptor Antagonists market, the applications of major players and the market size, and deeply analyzes the current situation of the global α-adrenoreceptor Antagonists market and the development prospects and opportunities of α-adrenoreceptor Antagonists industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global α-adrenoreceptor Antagonists market in Chapter 13.
By Player:
Astra Zeneca
Merck
Sanofi
Teva Pharmaceutical
Bayer
GSK
Novartis
Pfizer
Bristol-Myers Squibb
Jhonson and Johnson
Eli Lilly
By Type:
Non-selective Antagonists
Selective Antagonists
By End-User:
Hypertension
Raynaud's Disease
Erectile Dysfunction
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 α-adrenoreceptor Antagonists Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 α-adrenoreceptor Antagonists Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 α-adrenoreceptor Antagonists Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 α-adrenoreceptor Antagonists Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise α-adrenoreceptor Antagonists Market Analysis and Outlook to 2022
-
7.1 Global α-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.2 United States α-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.3 Europe α-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.4 China α-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.5 Japan α-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.6 India α-adrenoreceptor Antagonists Consumption (2017-2022)
-
7.7 South Korea α-adrenoreceptor Antagonists Consumption (2017-2022)
8 Region and Country-wise α-adrenoreceptor Antagonists Market Analysis and Outlook to 2028
-
8.1 Global α-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.2 United States α-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.3 Europe α-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.4 China α-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.5 Japan α-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.6 India α-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
-
8.7 South Korea α-adrenoreceptor Antagonists Consumption Forecast (2022-2028)
9 Global α-adrenoreceptor Antagonists Market Outlook by Types and Applications to 2022
-
9.1 Global α-adrenoreceptor Antagonists Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Non-selective Antagonists Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Selective Antagonists Consumption and Growth Rate (2017-2022)
-
9.2 Global α-adrenoreceptor Antagonists Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Raynaud's Disease Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Erectile Dysfunction Consumption and Growth Rate (2017-2022)
10 Global α-adrenoreceptor Antagonists Market Outlook by Types and Applications to 2028
-
10.1 Global α-adrenoreceptor Antagonists Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Non-selective Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Selective Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global α-adrenoreceptor Antagonists Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Raynaud's Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Erectile Dysfunction Consumption Forecast and Growth Rate (2022-2028)
11 Global α-adrenoreceptor Antagonists Import and Export Analysis (Top 5 Countries)
-
11.1 Global α-adrenoreceptor Antagonists Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global α-adrenoreceptor Antagonists Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 α-adrenoreceptor Antagonists Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global α-adrenoreceptor Antagonists Market Competitive Analysis
-
14.1 Astra Zeneca
-
14.1.1 Astra Zeneca Company Details
-
14.1.2 Astra Zeneca α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Astra Zeneca α-adrenoreceptor Antagonists Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck α-adrenoreceptor Antagonists Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi α-adrenoreceptor Antagonists Product and Service
-
14.4 Teva Pharmaceutical
-
14.4.1 Teva Pharmaceutical Company Details
-
14.4.2 Teva Pharmaceutical α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Pharmaceutical α-adrenoreceptor Antagonists Product and Service
-
14.5 Bayer
-
14.5.1 Bayer Company Details
-
14.5.2 Bayer α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer α-adrenoreceptor Antagonists Product and Service
-
14.6 GSK
-
14.6.1 GSK Company Details
-
14.6.2 GSK α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GSK α-adrenoreceptor Antagonists Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis α-adrenoreceptor Antagonists Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer α-adrenoreceptor Antagonists Product and Service
-
14.9 Bristol-Myers Squibb
-
14.9.1 Bristol-Myers Squibb Company Details
-
14.9.2 Bristol-Myers Squibb α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bristol-Myers Squibb α-adrenoreceptor Antagonists Product and Service
-
14.10 Jhonson and Johnson
-
14.10.1 Jhonson and Johnson Company Details
-
14.10.2 Jhonson and Johnson α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Jhonson and Johnson α-adrenoreceptor Antagonists Product and Service
-
14.11 Eli Lilly
-
14.11.1 Eli Lilly Company Details
-
14.11.2 Eli Lilly α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Eli Lilly α-adrenoreceptor Antagonists Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of α-adrenoreceptor Antagonists
-
Figure α-adrenoreceptor Antagonists Picture
-
Table Global α-adrenoreceptor Antagonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global α-adrenoreceptor Antagonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global α-adrenoreceptor Antagonists Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global α-adrenoreceptor Antagonists Consumption by Country (2017-2022)
-
Figure United States α-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Table Europe α-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure China α-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Japan α-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure India α-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure South Korea α-adrenoreceptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global α-adrenoreceptor Antagonists Consumption Forecast by Country (2022-2028)
-
Figure United States α-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe α-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure China α-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan α-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure India α-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea α-adrenoreceptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-selective Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Selective Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Raynaud's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Erectile Dysfunction Consumption and Growth Rate (2017-2022)
-
Figure Global Non-selective Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Selective Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Raynaud's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erectile Dysfunction Consumption Forecast and Growth Rate (2022-2028)
-
Table Global α-adrenoreceptor Antagonists Import by Region (Top 5 Countries) (2017-2028)
-
Table Global α-adrenoreceptor Antagonists Export by Region (Top 5 Countries) (2017-2028)
-
Table Astra Zeneca (Foundation Year, Company Profile and etc.)
-
Table Astra Zeneca α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astra Zeneca α-adrenoreceptor Antagonists Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck α-adrenoreceptor Antagonists Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi α-adrenoreceptor Antagonists Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical α-adrenoreceptor Antagonists Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer α-adrenoreceptor Antagonists Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK α-adrenoreceptor Antagonists Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis α-adrenoreceptor Antagonists Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer α-adrenoreceptor Antagonists Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb α-adrenoreceptor Antagonists Product and Service
-
Table Jhonson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Jhonson and Johnson α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jhonson and Johnson α-adrenoreceptor Antagonists Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly α-adrenoreceptor Antagonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly α-adrenoreceptor Antagonists Product and Service
-
